Peptide Payment Processing for Startups: How to Get Approved With Zero History
A new research-only peptide business can be completely legitimate and still have zero card-processing history. That should not automatically end the conversation. What matters is whether the business is real, compliant, stocked, launch-ready, and prepared for underwriting.
Yes. PeptidePay USA can review qualified research-only peptide startups with zero previous processing history when peptide inventory is physically in stock and the business is operationally ready. Approval is never automatic and remains subject to underwriting, program eligibility, and final approval.
Can a peptide startup get payment processing with zero history?
If your main concern is whether a brand-new peptide business can qualify without merchant statements, read our guide to peptide payment processing without processing history.
Yes—zero processing history is not the same thing as a bad processing history. A startup simply has not had the opportunity to build merchant statements yet. The real question is whether the business is sufficiently complete for a processor to evaluate.
For a research-only peptide startup, underwriting is likely to focus more heavily on the business itself: the website, products, labeling, ownership, banking, fulfillment, customer support, and whether the merchant is actually ready to accept and fulfill orders. A concept-stage business with no inventory and an unfinished website is very different from a fully built company that simply has not processed its first card transaction.
PeptidePay USA created a dedicated startup payment processing path for this exact situation. Established merchants remain welcome too, but startups are not forced to pretend they have processing statements that do not exist.
What matters instead of processing history?
When you cannot provide merchant statements, you need to demonstrate readiness in other ways. The stronger and cleaner the business looks, the easier it is for an underwriting team to understand what you sell, how you operate, and how customers will be supported.
Your research-only peptide inventory should already be on hand and available to fulfill orders.
Underwriters need to see a real storefront, products, policies, contact information, and clear business positioning.
Your website and product presentation should consistently position the products for research use only.
Product labeling and supporting documentation should be available when requested during review.
A legitimate business settlement account should be ready for onboarding and ownership verification.
You should be able to explain how orders are packed, shipped, tracked, delivered, refunded, and supported.
Why does inventory need to be physically in stock?
The startup program is designed for launch-ready businesses, not future concepts. Inventory in stock is a strong signal that the merchant is capable of fulfilling the orders it intends to accept.
From a payments perspective, fulfillment matters because unfulfilled orders can turn into refunds, customer complaints, and chargebacks. A startup that already has products in hand, a working shipping process, and clear customer-service procedures presents a very different operating picture from a merchant that intends to source products only after collecting customer payments.
Practical rule: if your peptide inventory has not arrived yet, finish preparing the business first and apply when you are genuinely ready to fulfill orders.
Website requirements for research-only peptide startups
Your website is one of the most important parts of a startup review because it gives underwriters a direct view into the business. The goal is to make the business easy to understand.
Your website should make these points clear
- The products are sold strictly for research use only.
- Product labeling is consistent with your research-only positioning.
- Customer support and contact information are easy to find.
- Shipping, refund, privacy, and terms policies are accessible.
- Your products and business identity are presented consistently.
- The website is complete enough for a customer and an underwriter to understand how the business operates.
For more detail, review the Research-Only Peptide Requirements FAQ before you submit an application.
What should you avoid?
PeptidePay USA is built around research-only / RUO merchants. Human-consumption positioning, dosage or ingestion instructions, treatment claims, therapeutic promises, or medical-use positioning can create underwriting problems and may make a business ineligible for the program.
What documents should a startup have ready?
A startup with zero history does not need to manufacture merchant statements. Instead, prepare the business information and supporting documents that actually exist.
- Business legal name and entity information
- Ownership and identity information
- Business banking information
- Website URL
- Product list and expected monthly volume
- Average expected order size
- Research-only product labels
- COAs or supporting product documentation when requested
- Inventory and fulfillment readiness
- Customer-service and refund procedures
Sensitive ownership, banking, identification, and supporting documents are completed through the secure Boardvia onboarding workflow, not through a public webpage form. The Quick Start Guide helps you choose the correct path and prepare before you apply.
How the PeptidePay USA startup application works
1. Confirm that the business is launch-ready
Make sure the website is live, the research-only positioning is consistent, the peptide inventory is in stock, business banking is ready, and the fulfillment process is in place.
2. Use the startup path
Visit the PeptidePay USA Startup Program or the Quick Start Guide and choose the startup / zero-history path.
3. Complete the secure application
Your application and supporting documents are completed through Boardvia. If you have zero processing history, the review focuses on the business information that is actually available rather than requiring nonexistent statements.
4. Underwriting review
PeptidePay USA reviews the business, website, products, banking, ownership, and supporting documentation. Approval, rates, settlement timing, and account terms remain subject to underwriting and merchant eligibility.
5. Onboarding and go-live
Approved merchants move into account setup and onboarding so payment processing can be integrated into the business.
What does startup peptide payment processing cost?
PeptidePay USA uses advertised volume-based pricing. For qualified startups processing up to $50,000 per month, the current advertised startup tier is:
Startup / Zero-History Tier
Up to $50,000 in monthly processing volume. The advertised program includes no-reserve processing and next-day settlements for approved eligible accounts, subject to underwriting and program terms.
View All Pricing Tiers →As monthly processing volume grows, lower advertised pricing tiers may be available. Review the complete PeptidePay USA pricing page for the current volume levels.
No reserve does not mean no underwriting
“No reserve” is a program feature, not a promise that every merchant will be approved. Peptide businesses are often treated as higher-risk by payment providers because processors evaluate factors such as product positioning, disputes, fulfillment, regulatory exposure, marketing practices, and chargeback risk.
PeptidePay USA’s advertised program offers no-reserve processing for approved eligible research-only peptide merchants. Underwriting still matters, and the business must remain within the program’s requirements.
If you want a deeper explanation of how reserves are commonly used in this industry, read High-Risk Peptide Payment Processing.
Common reasons a startup application gets delayed
Most delays are not caused by the fact that a business is new. They are caused by missing information or an operation that is not yet ready to be reviewed.
- Inventory is not physically in stock.
- The website is unfinished or still full of placeholder content.
- Research-only language is inconsistent across the site.
- Labels, COAs, policies, or business documents are missing.
- Business banking is not ready.
- The merchant cannot clearly explain shipping and fulfillment.
- Product pages contain unsupported medical, therapeutic, dosage, or human-use claims.
- The application is incomplete or ownership information does not match supporting documents.
The fastest application is usually the one submitted after the business is fully prepared—not the one submitted earliest.
Frequently asked questions about peptide startup processing
Can I apply with absolutely zero card-processing history?
Yes. Qualified startups may be reviewed with zero processing history when the business is launch-ready and research-only peptide inventory is physically in stock.
Do I need merchant statements if I have never processed before?
No. A true startup cannot provide statements that do not exist. The review instead relies more heavily on your business, website, inventory, banking, product documentation, and operating readiness.
Can I apply before my peptide inventory arrives?
The startup path is intended for launch-ready businesses. Wait until the research-only peptide inventory is physically in stock and you can fulfill customer orders.
Does zero processing history guarantee approval?
No. Startup eligibility does not guarantee approval. All accounts remain subject to underwriting, program requirements, and final approval.
Can an established peptide merchant use the same program?
Yes. Established research-only peptide merchants can apply and should provide recent processing statements, volume, and dispute information when available.
Does PeptidePay USA offer no-reserve processing?
The advertised program offers no-reserve processing for approved eligible research-only peptide merchants, subject to underwriting and program terms.
Where do I submit sensitive application documents?
Sensitive business, ownership, banking, identification, and supporting documents are completed through the secure Boardvia onboarding workflow.
Zero history does not have to mean zero options.
If your research-only peptide business is stocked, compliant, and ready to launch, start with the PeptidePay USA startup path and prepare the right information before underwriting.
PeptidePay USA supports businesses selling products strictly for research use only. Startup applications with zero prior processing history may be considered when the business is operationally ready and inventory is in stock. Rates, approval, settlement timing, no-reserve eligibility, and account terms are subject to underwriting, program requirements, and final approval.